Analysis of the North American Oral Solid Drug Dosage Excipients Market

Blockbuster Drug Patent Expiration Expected to Boost Market Growth

  • Research Code : NC51-01-00-00-00
  • SKU : CM00093-NA-MR_00398
  • Share this :
  • Release Date : 15-May-2013
  • Region : North America
  • Request Study Sample

Availability: In stock

Excipients are used to support the delivery of the APIs (active pharmaceutical ingredients) through oral dosage, parenteral, and transdermal medications. For oral dosages, the key delivery forms are tablets and capsules. This research service covers the North American oral solid drug dosage excipients market. Based on functionality, excipients are segmented as follows: binders and fillers, disintegrants, coatings, flavors, colors, sweeteners, glidants, adhesives, lubricants, and others. Units are defined in terms of tons. Unit shipment forecasts are based on the volume of excipients used in oral solid drug dosage formulations. The base year for the study is 2012, with a market history from 2009 and a forecast through 2019.

Regular Price: USD 4,950

Special Price USD 4,208

15% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 4,208

Pay By Invoice

Be the first to review this product

Related Research

1. Primary Research

Our analysis is based on comprehensive primary research conducted with core market participants.

2. Global Coverage

Unparalleled coverage of geographies, our analyst & consultant teams are based in 42+ offices spanning the globe.

3. Breadth of Vertical Industries

We cover the broadest spectrum of markets to provide our clients with the most relevant analysis and transformational insights.

4. Visionary Innovation Research

With on-going transformational shifts, our visionary innovation research prepares you with information on key megatrends shaping the future of your industry.

5. Mega Trends

Mega Trends are global forces that transform business, societies and economies.

6. Convergence Research Coverage

Taking an approach of analysing a macro-to-micro impact, our convergence research helps you prepare against an impending 'Kodak moment'.